Vaccine developer Intravacc launches hybrid business model to drive innovation and growth

September 16, 2021   |   September 2021 Bond Updates
BILTHOVEN, Netherlands, Sept. 16, 2021 /PRNewswire/ -- Intravacc, a global leader in translational research and the development of vaccines against infectious diseases and therapeutic vaccines, today launches its new hybrid business model that should lead to further innovation and...

View more at: https://www.prnewswire.com:443/news-releases/vaccine-developer-intravacc-launches-hybrid-business-model-to-drive-innovation-and-growth-301378153.html
 
Related News
Home| About us | Contact us http://www.bondupdatesdailynews.com/